Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)
Summary: Post hoc analysis of the results of the controlled rosuvastatin multinational trial in heart failure (CORONA)of the prognostic significance of intermittent claudication in patients with ischemic systolic heart failure.